Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Prostate cancer

Reducing IGF-1 levels unlikely to ProtecT against prostate cancer initiation

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

ORIGINAL RESEARCH PAPER

  1. Rowlands, M.-A. et al. Circulating insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) in PSA-detected prostate cancer: the large case control study ProtecT. Cancer Res. doi:10.1158/0008-5472.CAN-11-1601

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Clyne, M. Reducing IGF-1 levels unlikely to ProtecT against prostate cancer initiation. Nat Rev Urol 9, 6–7 (2012). https://doi.org/10.1038/nrurol.2011.211

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2011.211

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer